Connect with us

Cigna Collaboration Helps Santa Clara County IPA (SCCIPA) Improve Quality and Lower Costs

Published

on

Reading Time: 3 minutes

SANTA CLARA, Calif.–(BUSINESS WIRE)–The latest results from a collaboration between Cigna and Santa Clara
County IPA (SCCIPA) show that the program continues to drive better
health care quality for nearly 18,000 Silicon Valley residents while
achieving significantly better affordability.

SCCIPA enhances care by using patient-specific data from Cigna to help
identify individuals being discharged from the hospital who might be at
risk for readmission, as well as people who may be overdue for important
health screenings or who may have skipped a prescription refill. The
physician-led care team also helps patients get the follow-up care or
screenings they need, identifies potential complications related to
medications and helps prevent chronic conditions from worsening.

While SCCIPA already beats the market in affordability with total
medical costs that are 18 percent below market average, the medical
group’s cost trend was 2.6 percent lower than the market trend during
the period ending Sept. 30, 2018.

At the same time, the group’s quality score improved by double digits –
nearly 20 percentage points, led by better care of patients with cardiac
conditions, diabetes, depression and those requiring specific preventive
screenings.

Numerous factors contributed to SCCIPA’s strong performance results
compared to the market, including:

  • Hospital readmissions were 23 percent lower than market
  • Inpatient admissions among all services were 10 percent lower than
    market
  • Emergency room visits were 9 percent lower than market
  • Advanced imaging (CT scans and MRIs) were used 32 percent less than
    market
  • Inpatient total medical cost (per Cigna customer per month) was 20
    percent lower than market

“As a risk-bearing network of more than 800 physicians, we’re very
pleased with these positive results,” said John Kersten Kraft, M.D.,
president of SCCIPA. “SCCIPA is devoted to improving the measurable
quality of medical intervention received by our patients while
controlling the cost of their care. We value our strong and
exceptionally collaborative relationship with Cigna. Without this
relationship, these results could not be achieved. Together, we are
having a very positive impact on the health of our patients.”

“When health plans and health care providers work together toward a
common goal, the result is better health and affordability for the
people we jointly serve,” said Ken Phenow, M.D., M.P.H, market medical
executive for Cigna in Northern California. “We congratulate Santa Clara
County IPA for its laser focus on quality improvement that drove these
outstanding results.”

Since Cigna began collaborating with SCCIPA in 2014, the group has
demonstrated some of the most consistent performance, not only among
other medical groups in Northern California and Cigna’s Western Region,
but also among the more than 225 Collaborative Care arrangements Cigna
has with provider groups nationwide. In 2018, SCCIPA was the top
performing Cigna Collaborative Care group nationally.

In addition to its Collaborative Care arrangement with Cigna, SCCIPA is
also part of an alliance between Cigna and Good Samaritan Health System,
which includes Regional Medical Center of San Jose and Good Samaritan
Hospital. The alliance launched in January 2018 and offers a customized
network of primary care doctors, specialists and hospitals that provide
high value care.

About Santa Clara County IPA

Santa Clara County IPA (SCCIPA) has been providing exceptional
healthcare services for more than 30 years. More than 240 primary care
physicians and 600 specialists are focused on delivering the highest
quality of care, while driving lower cost of care for more than 90,000
members of major HMOs, PPOs, ACOs and Medicare Advantage programs.
SCCIPA’s mission is to connect patients to independent doctors who are
passionate about providing personalized care. The diverse network
includes access to 13 urgent care centers, 10 hospitals, radiology,
clinical labs, physical therapists, and case managers dedicated to
providing care with a purpose. SCCIPA offers a multitude of services for
members and is known for its Care Concierge program. The program is led
by a team of clinicians and is designed to engage patients and promote
healthy habits, behavioral change, improved health, and ultimately lower
cost of care by helping members be at their best. Visit www.sccipa.com.

About Cigna

Cigna Corporation (NYSE: CI) is a global health service company
dedicated to improving the health, well-being and peace of mind of those
we serve. Cigna delivers choice, predictability, affordability and
quality care through integrated capabilities and connected, personalized
solutions that advance whole person health. All products and services
are provided exclusively by or through operating subsidiaries of Cigna
Corporation, including Cigna Health and Life Insurance Company,
Connecticut General Life Insurance Company, Life Insurance Company of
North America, Cigna Life Insurance Company of New York, Express Scripts
companies or their affiliates. Such products and services include an
integrated suite of health services, such as medical, dental, behavioral
health, pharmacy, vision, supplemental benefits, and other related
products including group life, accident and disability insurance. Cigna
maintains sales capability in over 30 countries and jurisdictions, and
has more than 160 million customer relationships throughout the world.
To learn more about Cigna®, including links to follow us on
Facebook or Twitter, visit www.cigna.com.

Contacts

Mark Slitt
Cigna
860.226.2092
Mark.Slitt@cigna.com

Janet Doherty Pulliam
Pacific Partners Management Services, Inc.
650.358.5715
jpulliam@ppmsi.com

Cannabis

Oppenheimer & Co. To Host 19th Annual Consumer Growth and E-Commerce Conference

Published

on

Reading Time: 2 minutes

 

Oppenheimer & Co. Inc. (“Oppenheimer”) – a leading investment bank, wealth manager, and a subsidiary of Oppenheimer Holdings (NYSE: OPY) – will host its 19th Annual Consumer Growth and E-Commerce Conference on June 18-19 in Boston, MA. This year’s event features companies from prominent consumer brands such as Autozone, Domino’s Pizza, Express, Home Depot, Lowe’s, Six Flags Theme Parks, Tiffany & Company, Ulta, Walmart, Weight Watchers, and Yum Brands.

Of particular note, Oppenheimer is pleased to host nine of the market-leading companies involved with emerging trends in the Cannabis space this year. The event will also feature seven panel discussions, moderated by Oppenheimer Consumer Research Analysts, addressing emerging and disruptive trends in the consumer marketplace as follows:

  • Evolving Role of Technology in the Consumer Sector with Cooler Screens and Lindsay Goldberg LLC, moderated by Brian Nagel
  • A Discussion with Emerging Restaurant Brands with Aurify and B. Good, moderated by Brian Bittner
  • A Discussion on the Evolving US Food & Beverage Landscape with Lifeway, New Age Beverage, and United Natural Foods, moderated by Rupesh Parikh
  • Next Gen Brands Re-Shaping Landscape for Women’s Fashion with CARAA and Rothy’s, moderated by Brian Nagel
  • Exciting New Brands Shaking Up Home Products Space with Burkelman, LoveSac and Resident/Nectar, moderated by Brian Nagel
  • A Discussion on the Emerging CBD Landscape with Curaleaf and CV Sciences, moderated by Rupesh Parikh
  • Leveraging the Power of Digital to Connect with Consumers with Eight and FlexShopper, moderated by Brian Nagel

The conference features Oppenheimer’s Consumer Senior Research Analysts:

  • Brian Bittner, Managing Director Senior Analyst covering Restaurants
  • Brian Nagel, Managing Director and Senior Analyst covering Retail and E-Commerce
  • Rupesh Parikh, Managing Director and Senior Analyst covering Food, Grocery and Consumer Products
  • Ian Zaffino, Managing Director and Senior Analyst covering event-driven Special Situations

“Long-established business models are being upended by disruptive brands and technology, affecting consumer preferences and buying behaviors throughout the consumer industry. This year’s event aims to showcase the mix of market-leading and emerging companies driving and navigating these changes,” said Erica L. Moffett, Managing Director and Associate Director of Research at Oppenheimer. “From effortless payment methods to accelerated delivery times and customized products, consumers want a seamless experience. In order to succeed, companies must stay current on the evolving consumer and we are pleased to host a conference to explore this new landscape.”

Oppenheimer’s next conference will be the Montauk Emerging Life Sciences Summit, which will be held on June 26-28in Montauk, NY. The 22nd Annual Technology, Internet & Communications Conference will follow on August 6-7 in Boston, MA, followed by the Midwest Corporate Access Day in Chicago on August 15.

Oppenheimer & Co. Inc.
Oppenheimer & Co. Inc. (Oppenheimer), a principal subsidiary of Oppenheimer Holdings Inc. (OPY on the New York Stock Exchange), and its affiliates provide a full range of wealth management, securities brokerage and investment banking services to high-net-worth individuals, families, corporate executives, local governments, businesses and institutions.

SOURCE Oppenheimer & Co. Inc.

Continue Reading

Cannabis

iCAN: Israel-Cannabis CEO and Founder Saul Kaye to Participate at the World Cannabis Congress in Saint John, New Brunswick

Published

on

Reading Time: 1 minute

 

iCAN: Israel Cannabis Founder and CEO Saul Kaye will participate at the World Cannabis Conference being held in Saint John, New Brunswick, Canada from June 16-18, 2019.

Kaye, a leader in the global cannabis ecosystem will moderate a session entitled, “Innovative Methodologies and Emerging Topics in Global Cannabis Research.”  Panelists are Dr. Suzanne Sisley MD President and Principal Investigator, Scottsdale Research Institute and, Dr. Jerry King, R&D Consultant, CFS.  The session will take place at the Saint John Trade & Convention Centre on June 18.

The World Cannabis Congress (WCC) is an exclusive, invite-only event for international cannabis leaders, influencers and trend setters. The event will have hundreds of attendees from around the world from business, government and medicine.

In addition to his leadership of iCAN: Israel Cannabis, Kaye is an industry advisor to the Medical Cannabis Caucus of the Israeli Parliament, as well as an advisor to the Ministries of Economy and Health in Israel. He is a licensed pharmacist and a successful entrepreneur with both retail and e-commerce experience. Saul has founded multiple companies spanning six countries across the US, EuropeIsrael and Australia.

Canada has truly been a global trailblazer in the cannabis industry.  Canadian cannabis companies and its stock market are influential and forward looking and we in Israel, the R&D capital of cannabis, collaborate with our Canadian friends on many different levels.  I look forward to participating at the WCC as the medicine and business of cannabis develops at breathtaking speed both in Israel and beyond,” said Kaye.

 

SOURCE iCAN: Israel Cannabis

Continue Reading

Cannabis

Loyalist College to launch Canada’s first Technology Access Centre for natural products and cannabis

Published

on

Reading Time: 3 minutes

 

Loyalist College is the recipient of a $1,750,000 Natural Sciences and Engineering Research Council of Canada (NSERC) College and Community Innovation (CCI) Program grant over five years to launch Canada’s first Technology Access Centre (TAC) for natural products and cannabis. In addition, Loyalist received $1Mthrough the Canada Foundation for Innovation’s (CFI) College-Industry Innovation Fund (CIIF) to add specialized equipment to the TAC.

Loyalist was one of 90 recipients at colleges, cégeps and polytechnics across the country to receive part of the $73M in funding, announced today by the Honourable Kirsty Duncan, Minister of Science and Sport, at Georgian College in Barrie, Ontario. Through the CCI Program and the CIIF, this investment will help post-secondary institutions partner directly with local employers to facilitate commercialization and transform the results of research and development into new technologies to help businesses expand and grow.

The rapid growth of Canada’s cannabis, hops and natural products sectors positions Loyalist’s Applied Research Centre for Natural Products and Medical Cannabis (ARC) as a national innovation hub for small- to medium-sized enterprises. As a TAC, Loyalist will build on the ARC’s 15 years of natural product extraction expertise and analysis-based applied research. In transitioning to a TAC, Loyalist’s ARC will significantly increase the College’s capacity to lead applied research of commercially relevant natural products and cannabis, and to support innovation by enhancing industries’ access to sector-relevant expertise and technology.

The TAC initiative will cultivate an environment for College-industry partnerships to thrive while providing students with unparalleled opportunities for work-integrated learning; investigating extraction, isolation, and formulation; and product development. In partnership with the Quinte Economic Development Commission (QEDC), Loyalist will support the Bay of Quinte’s burgeoning natural products and cannabis sectors to generate regional socioeconomic benefits, and to provide opportunities for a new generation of innovators. Loyalist will also offer companies across Canada a supportive, community-oriented platform from which to enhance their productivity, expand their reach and augment their competitiveness in the global market.

Quotes

“We are very grateful for NSERC’s continued support and proud to be Canada’s first TAC for natural products and cannabis. Loyalist currently has more than 25 companies interested in applied research, and as our ARC transitions into a TAC, we will be able to meet their requirements while significantly extending our network to help more companies to innovate. Our Biosciences and Cannabis Applied Science students will have the advantage of being involved in ground-breaking research that propels Canada forward as the world leader in cannabis and natural product developments.” – Dr. Ann Marie Vaughan, Loyalist College President & CEO

“It’s great to see this NSERC and CFI funding come through for Loyalist College’s launch of Canada’s first TAC for research in natural products and cannabis. Being able to conduct research in a state-of-the-art facility means that students working in the College’s ARC will be able to build up their expertise in product analysis; which can then be applied directly to commercial development. This is just the beginning of seeing a new series of natural products being designed, assessed, made and delivered from our region.” – Neil R. Ellis, Member of Parliament for Bay of Quinte

“I am so proud to see the innovation that is driving research and economic development in our rural community through Loyalist College’s ARC. Innovation is key to Rural Sustainability and this investment will ensure that we are training the next generation in the latest technological advances. I congratulate them on their NSERC and CFI grant, and wish them all the best of success.” – Mike Bossio, Member of Parliament for Hastings—Lennox and Addington

“The Quinte Economic Development Commission is proud to be a supporting partner with Loyalist College on this important initiative that is aligned with economic development opportunities and priorities in the region. The TAC will support industry research and innovation for companies in key industry sectors as well as helping students develop in-demand skills and experience. Congratulations to the team at Loyalist on launching this important project.” – Chris King, Chief Executive Officer, Quinte Economic Development Commission

 

SOURCE Loyalist College

Continue Reading

Trending Online

Grassnews is a news publishing website which digests / hand picks the latest news about the cannabis industry, and serves them to you daily.

Contact us: pressroom@grassnews.net

© Grassnews.net 2019 - part of PICANTE Media. All rights reserved. Registered in Romania under Proshirt SRL, Company number: 2134306, EU VAT ID: RO21343605. Office address: Blvd. 1 Decembrie 1918 nr.5, Targu Mures, Romania